Overview


The Oncology Information System Market encompasses digital platforms and software that manage and optimize data for cancer care, including patient records and treatment planning. The market is growing rapidly due to rising cancer incidence, the adoption of AI-driven analytics, and the demand for interoperable, data-centric solutions in oncology.

According to FutureWise analysis, the Oncology Information System Market in 2026 is US$3.55 billion, and is expected to reach US$6.67 billion by 2036 at a CAGR of 6.51%. Oncology Information Systems (OIS) are gaining prominence due to the increasing prevalence of cancer, the demand for personalized treatment planning, and advancements in electronic health records. OIS streamlines clinical workflows, enhances collaboration among specialties, and supports data-driven decision-making, ultimately improving patient outcomes in radiation, medical, and surgical oncology.

Growth Drivers:

  • Rising global cancer incidence and increasing patient population.
  • Growing adoption of digital health solutions and AI-powered analytics in oncology.
  • Need for streamlined clinical workflows and improved treatment planning.
  • Increasing demand for interoperable, data-driven, and cloud-based healthcare systems.
  • Government initiatives and investments in advanced cancer care infrastructure.

Key Trends:

  • Increasing integration of artificial intelligence (AI) and predictive analytics to support clinical decision-making and personalized cancer care.
  • Growing adoption of cloud-based and SaaS-enabled OIS platforms for scalable, remote access and collaboration across care teams.
  • Expansion of telemedicine and remote patient monitoring features within oncology systems to support virtual consultations and follow-ups.
  • Emphasis on interoperability and EHR integration, enabling seamless data exchange across healthcare departments and systems.

Market Segmentation and Key Players:

The Oncology Information System Market is segmented by application (surgical, radiation, and medical oncology), by products and services (software and professional services), and by end users (hospitals, diagnostic labs, outpatient centers, and clinics). Major regions include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Oncology Information System Market, including Elekta AB and Cerner Corporation, provide OIS solutions to streamline cancer care, optimize treatment planning, and enhance clinical data management.

Research Methodology:

The research methodology for the Oncology Information System Market by FutureWise Research combines primary and secondary research to ensure data accuracy. Primary research includes interviews with key stakeholders like healthcare providers and technology vendors, while secondary research utilizes company reports and journals. Data validation through triangulation offers insights into market segmentation, competition, and growth opportunities.

  • Accuray Incorporated
  • Bogardus Medical Systems, Inc.
  • Cerner Corporation
  • CureMD Corporation
  • Elekta AB
  • Flatiron Health, Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • RaySearch Laboratories AB
  • Varian Medical Systems, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Oncology Information System Market:

Varian Medical Systems, Inc.

In January 2025, Varian introduced ARIA OIS 18.5, which features enhanced integration of artificial intelligence (AI) and a redesigned interface to improve usability for radiation oncology teams. This upgrade focuses on automating documentation and compliance tracking, thereby streamlining clinical workflows.

Elekta AB

Elekta is enhancing its Elekta ONE Oncology Information System (OIS) by integrating advanced imaging and treatment planning capabilities to support multidisciplinary cancer care. The system's goal is to improve clinical decision-making and patient outcomes through seamless data integration.

By Application

  • Surgical Oncology
  • Radiation Oncology
  • Medical Oncology

By Products and Services

  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Professional Services
    • Consulting/Optimization Services
    • Implementation Services
    • Post-sale and Maintenance Services

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Centres
  • Clinics

By Region

  • Europe
  • North America
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Here’s a regional view of where the most progress is happening:

The North America region continues to be at the forefront of developing and adopting Oncology Information Systems (OIS). Several factors are driving this growth, including:

1. High prevalence of cancer and a well-established healthcare infrastructure.

2. Strong government support and favorable reimbursement policies.

3. Early adoption of electronic health records (EHRs) and integrated healthcare solutions.

 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on Global Oncology Information System Market By Application, Products and Services Type, End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Oncology Information System Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Oncology Information System Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Oncology Information System Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Oncology Information System Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Oncology Information System Market, By Application Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Surgical Oncology
        2. Radiation Oncology
        3. Medical Oncology

  • 8.   Global Oncology Information System Market, By Products and Services Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Software
         1.1. Patient Information Systems
         1.2. Treatment Planning Systems
        2. Professional Services
         2.1. Consulting/Optimization Services
         2.2. Implementation Services
         2.3. Post-sale and Maintenance Services

  • 9.   Global Oncology Information System Market, By End User Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratories
        3. Outpatient Centres
        4. Clinics

  • 10.   North America Oncology Information System Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America Oncology Information System Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe Oncology Information System Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific Oncology Information System Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Oncology Information System Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Accuray Incorporated
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bogardus Medical Systems, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cerner Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. CureMD Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Elekta AB
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Flatiron Health, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Koninklijke Philips N.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. McKesson Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. RaySearch Laboratories AB
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Varian Medical Systems, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


OIS enhances patient care by enabling precise treatment planning, optimizing clinical workflows, promoting multidisciplinary collaboration, and supporting data-driven decision-making.

An OIS is a comprehensive software solution that manages cancer patient data, including treatment planning, scheduling, clinical documentation, imaging, and outcomes, thereby facilitating integrated cancer care.

Key components comprise treatment planning systems, patient scheduling, clinical workflow management, data analytics, reporting tools, and integration with hospital information systems (HIS) as well as electronic health records (EHR).

OIS is mainly used for radiation therapy planning, chemotherapy management, clinical documentation, patient scheduling, imaging data management, and tracking treatment outcomes.

Related Market

Radiology Information Systems Market

Read More

Critical Care Information Systems Market

Read More

RWE Oncology Market

Read More
Partner

Our Clients